Media

Press releases

• AlzeCure receives payment of EU grant for Phase 2 clinical trial with NeuroRestore ACD856 for Alzheimer’s disease
  December 3, 2025
• AlzeCure publishes its interim report for January – September 2025
  November 11, 2025
• Response letter to previous article published about Alzstatin’s unique mode of action against Alzheimer’s
  October 14, 2025

All press releases

Calendar

• AlzeCure to present at Redeye Life Science day December 3, 2025
• Interim report Q4, October–December 2025 February 26, 2026
• Annual report 2025 April 8, 2026

All events